✦ LIBER ✦

RRM1-based tailored chemotherapy for NSCLC?

Book ID: 120857921
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2004
Weight: 151 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200414320-00024

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictive effects of RRM1, ERCC1, XRCC3

Predictive effects of RRM1, ERCC1, XRCC3, BRCA1 and EGFR genotyping or expression for clinical outcome of advanced NSCLC patients treated with cisplatin–based chemotherapy or gefitinib

✍ Caicun Zhou; et al. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Cisplatin-based chemotherapy warranted i

Cisplatin-based chemotherapy warranted in advanced NSCLC

📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl ⚖ 121 KB

Predictive impact of RRM1 protein expres

Predictive impact of RRM1 protein expression on vinorelbine efficacy in NSCLC patients randomly assigned in a chemotherapy phase III trial

✍ Vilmar, A. C.; Santoni-Rugiu, E.; Sorensen, J. B. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 145 KB

Individualized chemotherapy in advanced

Individualized chemotherapy in advanced NSCLC patients based on mRNA levels ofBRCA1andRRM1

✍ Sheng-xiang Ren, Ai-wu Li, Song-wen Zhou, Ling Zhang, Yong-sheng Wang, Bing Li, 📂 Article 📅 2012 🏛 Chinese Anti-Cancer Association 🌐 English ⚖ 562 KB

RT-PCR versus immunohistochemistry for c

RT-PCR versus immunohistochemistry for correlation and quantification of ERCC1, BRCA1, TUBB3 and RRM1 in NSCLC

✍ Vilmar, A.; Garcia-Foncillas, J.; Huarriz, M.; Santoni-Rugiu, E.; Sorensen, J.B. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 655 KB

Cisplatin-based triple chemotherapy impr

Cisplatin-based triple chemotherapy improves QOL in NSCLC

✍ Todd, Carlene 📂 Article 📅 1999 🏛 Adis International Limited (now part of Wolters Kl ⚖ 123 KB